HBV viral load test validation study
Part of Digestive system, Infections clinical trials.
This study is testing a new blood test that measures the amount of hepatitis B virus (HBV) in your body. It helps see if the test works as well as current approved tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a prescription for a hepatitis B viral load test or have already been diagnosed with HBV.
- You can understand the study and give your informed consent.
- You are covered by a health insurance or social security system.
- You are not currently in another clinical study or under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This trial tests an experimental antibody treatment for people with chronic hepatitis B who have been on antiviral medication for at least 6 months. It aims to see if the antibody is safe and can help control the virus.
This study looks at new blood tests (biomarkers) to better understand chronic hepatitis B and how it affects treatment decisions. It may help doctors find better ways to manage your condition.
This trial is evaluating a new blood test (Accupower HCV) to measure the amount of hepatitis C virus in your blood. If you have or may have hepatitis C, this test may help show how well your treatment is working.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
Hear when a new Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.